Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto on sympathetic activity in heart failure
NCT03415906Phase 2Withdrawn
- Sponsor
- Hannover Medical School
- Start
- Dec 2017
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
A Phase 2 trial of sacubitril + valsartan in heart failure (HF), sponsored by Hannover Medical School. Planned start Dec 2017; status: withdrawn.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03415906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415906.